• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体表达通过细胞外信号调节激酶/微小RNA 200a信号通路影响非小细胞肺癌细胞的增殖和凋亡。

Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway.

作者信息

Zhou Ping, Hu Jian, Wang Xiaoqin, Wang Jingyuan, Zhang Yong, Wang Cong

机构信息

Clinical Laboratory, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Chest Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

出版信息

Oncol Lett. 2018 Apr;15(4):5201-5207. doi: 10.3892/ol.2018.7961. Epub 2018 Feb 6.

DOI:10.3892/ol.2018.7961
PMID:29552158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5840500/
Abstract

The present study assessed the function of epidermal growth factor receptor (EGFR) and its molecular targets in non-small cell lung cancer. The results of the present study demonstrated that EGFR protein and mRNA expression in the normal adjacent tissue specimens was decreased compared with that in the lung cancer tissue samples. Compared with the BEAS-2B normal bronchial epithelial cells, EGFR and phosphorylated (p)-extracellular signal-regulated kinase (ERK) protein expression in the SW-900 and A549 lung cancer cells was increased and microRNA (miR)200a expression in the SW-900 and A549 cells was inhibited compared with the BEAS-2B cells. Downregulating miR200a expression significantly suppressed proliferation and promoted apoptosis and caspase (CASP)3 and CASP9 function in the A549 cells and significantly inhibited EGFR and p-ERK protein expression in the A549 cells, compared with the BEAS-2B cells. The results of the present study indicated that downregulating miR200a significantly suppressed proliferation and promoted apoptosis in A549 cells via the regulation of the EGFR and ERK 1/2 signaling pathways.

摘要

本研究评估了表皮生长因子受体(EGFR)及其分子靶点在非小细胞肺癌中的功能。本研究结果表明,与肺癌组织样本相比,正常相邻组织标本中EGFR蛋白和mRNA表达降低。与BEAS-2B正常支气管上皮细胞相比,SW-900和A549肺癌细胞中EGFR和磷酸化(p)-细胞外信号调节激酶(ERK)蛋白表达增加,且与BEAS-2B细胞相比,SW-900和A549细胞中微小RNA(miR)200a表达受到抑制。与BEAS-2B细胞相比,下调miR200a表达显著抑制A549细胞的增殖并促进其凋亡以及半胱天冬酶(CASP)3和CASP9功能,且显著抑制A549细胞中EGFR和p-ERK蛋白表达。本研究结果表明,下调miR200a可通过调节EGFR和ERK 1/2信号通路显著抑制A549细胞的增殖并促进其凋亡。

相似文献

1
Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway.表皮生长因子受体表达通过细胞外信号调节激酶/微小RNA 200a信号通路影响非小细胞肺癌细胞的增殖和凋亡。
Oncol Lett. 2018 Apr;15(4):5201-5207. doi: 10.3892/ol.2018.7961. Epub 2018 Feb 6.
2
MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signaling.微小RNA-133a通过AKT/ERK信号通路下调人非小细胞肺癌细胞中表皮生长因子受体(EGFR)的表达。
Oncol Lett. 2018 Nov;16(5):6045-6050. doi: 10.3892/ol.2018.9399. Epub 2018 Sep 5.
3
Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.miRNA-133b 的过度调控通过靶向 EGFR 抑制顺铂诱导的非小细胞肺癌细胞的增殖,该调控作用是通过 PI3K/Akt 和 JAK2/STAT3 信号通路实现的。
Oncol Rep. 2018 Mar;39(3):1227-1234. doi: 10.3892/or.2018.6215. Epub 2018 Jan 15.
4
MicroRNA-7 Exerts Antiangiogenic Effect on Colorectal Cancer via ERK Signaling.miR-7 通过 ERK 信号通路对结直肠癌发挥抗血管生成作用。
J Surg Res. 2019 Aug;240:48-59. doi: 10.1016/j.jss.2019.02.035. Epub 2019 Mar 22.
5
Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway.通过胰岛素样生长因子受体1信号通路鉴定参与非小细胞肺癌吉非替尼耐药的微小RNA
Exp Ther Med. 2017 Oct;14(4):2853-2862. doi: 10.3892/etm.2017.4847. Epub 2017 Jul 28.
6
miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.miR-19b 通过靶向非小细胞肺癌中的 PP2A 和 BIM 增强 EGFR 信号通路促进增殖和抗凋亡。
Mol Cancer. 2018 Feb 19;17(1):44. doi: 10.1186/s12943-018-0781-5.
7
Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.Derlin-1 在非小细胞肺癌中过表达,并通过 EGFR-ERK 介导的 MMP-2 和 MMP-9 的上调促进癌细胞侵袭。
Am J Pathol. 2013 Mar;182(3):954-64. doi: 10.1016/j.ajpath.2012.11.019. Epub 2013 Jan 7.
8
[EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells].[表皮生长因子受体-细胞外信号调节激酶信号通路下调肺癌细胞中的微小RNA-145]
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):187-92. doi: 10.3760/cma.j.issn.0253-3766.2013.03.006.
9
Lysophosphatidic acid induces rapid and sustained decreases in epidermal growth factor receptor binding via different signaling pathways in BEAS-2B airway epithelial cells.溶血磷脂酸通过不同信号通路诱导BEAS-2B气道上皮细胞中表皮生长因子受体结合迅速且持续减少。
J Pharmacol Exp Ther. 2008 Jun;325(3):809-17. doi: 10.1124/jpet.107.133736. Epub 2008 Feb 28.
10
MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.微小 RNA-145 通过调控 EGFR/PI3K/AKT 信号通路抑制人非小细胞肺癌细胞迁移并诱导其凋亡。
Oncol Rep. 2018 Nov;40(5):2944-2954. doi: 10.3892/or.2018.6666. Epub 2018 Aug 23.

引用本文的文献

1
Heparan sulfate regulates amphiregulin programming of tissue reparative lung mesenchymal cells during influenza A virus infection in mice.硫酸乙酰肝素在小鼠甲型流感病毒感染期间调节组织修复性肺间充质细胞的双调蛋白编程。
Nat Commun. 2025 Mar 3;16(1):2129. doi: 10.1038/s41467-025-57362-z.
2
Squeezable Hydrogel Microparticles for Single Extracellular Vesicle Protein Profiling.用于单细胞外囊泡蛋白质谱分析的可挤压水凝胶微粒
Small. 2025 Jan;21(1):e2407809. doi: 10.1002/smll.202407809. Epub 2024 Oct 29.
3
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.用于靶向治疗携带表皮生长因子受体(EGFR)肿瘤的溶瘤单纯疱疹病毒。
Mol Ther Oncol. 2024 Jan 10;32(1):200761. doi: 10.1016/j.omton.2024.200761. eCollection 2024 Mar 21.
4
Effect of PTFGRN Expression on the Proteomic Profile of A431 Cells and Determination of the PTGFRN Interactome.PTFGRN表达对A431细胞蛋白质组图谱的影响及PTGFRN相互作用组的测定。
ACS Omega. 2024 Mar 15;9(12):14381-14387. doi: 10.1021/acsomega.4c00042. eCollection 2024 Mar 26.
5
Profiling of ERBB receptors and downstream pathways reveals selectivity and hidden properties of ERBB4 antagonists.ERBB受体及下游信号通路分析揭示了ERBB4拮抗剂的选择性和潜在特性。
iScience. 2024 Jan 9;27(2):108839. doi: 10.1016/j.isci.2024.108839. eCollection 2024 Feb 16.
6
Intragenic .E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.4331例实体瘤中的基因内E1E8融合(EGFRvIII)
Cancers (Basel). 2023 Dec 19;16(1):6. doi: 10.3390/cancers16010006.
7
Exploring the Potential of Lapatinib, Fulvestrant, and Paclitaxel Conjugated with Glycidylated PAMAM G4 Dendrimers for Cancer and Parasite Treatment.探索糖基化 PAMAM G4 树枝状大分子偶联拉帕替尼、氟维司群和紫杉醇在癌症和寄生虫病治疗中的潜力。
Molecules. 2023 Aug 30;28(17):6334. doi: 10.3390/molecules28176334.
8
Identification of the Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay.在无细胞检测中鉴定出活性成分布鲁斯他汀为一种表皮生长因子受体酪氨酸激酶抑制剂。
ACS Omega. 2023 Jul 28;8(31):28543-28552. doi: 10.1021/acsomega.3c02931. eCollection 2023 Aug 8.
9
Synthesis, Radiolabeling, and and Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αβ Targeting.用于双特异性靶向表皮生长因子受体(EGFR)和整合素αβ的异二价肽类药物的合成、放射性标记及表征
ACS Omega. 2023 Jan 4;8(2):2793-2807. doi: 10.1021/acsomega.2c07484. eCollection 2023 Jan 17.
10
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.新型 2-(5-芳基-4,5-二氢吡唑-1-基)噻唑-4-酮作为 EGFR 抑制剂:合成、生物学评估和分子对接研究。
Drug Des Devel Ther. 2022 May 16;16:1457-1471. doi: 10.2147/DDDT.S356988. eCollection 2022.

本文引用的文献

1
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis.免疫检查点抑制剂治疗的非小细胞肺癌患者吸烟状态的预后价值:一项荟萃分析。
Oncotarget. 2017 Jun 28;8(54):93149-93155. doi: 10.18632/oncotarget.18703. eCollection 2017 Nov 3.
2
Prognostic value of number of negative lymph node in patients with stage II and IIIa non-small cell lung cancer.Ⅱ期和Ⅲa期非小细胞肺癌患者阴性淋巴结数量的预后价值
Oncotarget. 2017 May 24;8(45):79387-79396. doi: 10.18632/oncotarget.18154. eCollection 2017 Oct 3.
3
CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding.CBP501通过阻断KRas与钙调蛋白的结合,抑制非小细胞肺癌细胞中表皮生长因子依赖的细胞迁移、侵袭及上皮-间质转化。
Oncotarget. 2017 Jun 22;8(43):74006-74018. doi: 10.18632/oncotarget.18598. eCollection 2017 Sep 26.
4
Assessment and prognostic analysis of EGFR mutations or/and HER2 overexpression in Uygur's Non-small Cell Lung Cancer.维吾尔族非小细胞肺癌中表皮生长因子受体(EGFR)突变和/或人表皮生长因子受体2(HER2)过表达的评估及预后分析
Int J Clin Exp Med. 2015 Dec 15;8(12):22300-9. eCollection 2015.
5
The dynamic subcellular localization of ERK: mechanisms of translocation and role in various organelles.细胞外信号调节激酶(ERK)的动态亚细胞定位:转运机制及其在各种细胞器中的作用
Curr Opin Cell Biol. 2016 Apr;39:15-20. doi: 10.1016/j.ceb.2016.01.007. Epub 2016 Jan 29.
6
MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.微小RNA-125b通过靶向鞘氨醇激酶1抑制膀胱癌的增殖和迁移。
Am J Transl Res. 2015 Nov 15;7(11):2346-54. eCollection 2015.
7
Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.表皮生长因子受体(EGFR)突变与血清环氧化酶-2水平的关系,以及塞来昔布和吉非替尼对非小细胞肺癌细胞中EGFR表达的协同作用。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9010-20. eCollection 2015.
8
Phase I/IIa study of sequential chemotherapy regimen of bendamustine/irinotecan followed by etoposide/carboplatin in untreated patients with extensive disease small cell lung cancer (EDSCLC).苯达莫司汀/伊立替康序贯化疗方案随后联合依托泊苷/卡铂用于初治广泛期小细胞肺癌(EDSCLC)患者的I/IIa期研究。
Cancer Chemother Pharmacol. 2015 Nov;76(5):949-55. doi: 10.1007/s00280-015-2869-6. Epub 2015 Sep 22.
9
Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.循环可溶性表皮生长因子受体在非小细胞肺癌中的诊断及分子作用的初步证据
Int J Mol Sci. 2015 Aug 19;16(8):19612-30. doi: 10.3390/ijms160819612.
10
Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.表皮生长因子受体(EGFR)和AKT1基因多态性作为接受EGFR酪氨酸激酶抑制剂治疗的晚期非小细胞肺癌患者临床结局的可能预测指标。
Tumour Biol. 2016 Jan;37(1):1061-9. doi: 10.1007/s13277-015-3893-1. Epub 2015 Aug 14.